HB 1078 North Carolina House · 2025-2026 Session

Omnibus Life Sciences Appropriations.

HB 1078 is an omnibus appropriations bill that provides funding to the Department of Commerce and the Department of Health and Human Services in North Carolina. The legislation allocates $10 million to the One North Carolina Small Business Account and $2 million to the North Carolina Biotechnology Center to support life science companies, university research, workforce development, and economic programs. Additionally, the bill transfers the Advisory Council on Rare Diseases from the Department of Commerce to the Department of Health and Human Services and establishes a new Life Science and Biomanufacturing Technologies Reserve Fund. The bill also details the composition, membership, and administrative structure of the rare diseases council, which includes physicians, researchers, patient representatives, and industry experts.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2026
Committee Review
Floor Vote
Governor
Introduced Apr 28, 2026 Last action Apr 29, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Filed Edition 1 · 2 edits
MINOR
The bill's formatting and header information were updated to reflect the current session and include additional sponsors. The substantive text regarding the establishment of the Advisory Council on Rare Diseases, including its membership composition and appointment process, remains unchanged in this version.
TECHNICAL

The bill title page was updated with new session dates and added secondary sponsors (Representatives White and Reives) to the sponsor list.

The internal bill identifier was changed from 'DRH10592-NIa-190C' to 'H1078-v-1' to reflect the new bill number and edition.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
Apr 29, 2026
Committee
Ref to the Com on Appropriations, if favorable, Rules, Calendar, and Operations of the House
lower
Apr 28, 2026
Introduced
Filed
lower
1 primary · 22 co-sponsors

Sponsors